key: cord-0052735-ufwx23b0 authors: Huang, Xi; Zhao, Qiulong; Xia, Liang; Shi, Shaoqi title: Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’ date: 2020-11-13 journal: Pharmacol Res DOI: 10.1016/j.phrs.2020.105289 sha: 68b102c66120df702188ffe37fcad598ee57f85b doc_id: 52735 cord_uid: ufwx23b0 nan wherein SARS-CoV-2 replication, virus morphology, and the number of virus particles in Vero E6 cells as well as mRNA levels of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β, IL-8, CCL-2/MCP-1, and CXCL-10/IP-10) in Huh-7 cells were directly inhibited or reduced by crude extracts of Lianhuaqingwen (LH, 150-600 μg·mL -1 ) and Liu Shen (LS, 0.25-2 μg·mL -1 ). This was further supported by the clinical analysis of LH efficacy against COVID-19 [3] . These in vivo/vitro observations prove to be meaningful as COVID-19, owing to its fast-spreading nature, has become a global threat with no or scarcely available antivirals or vaccine. Moreover, LH and LS crude extracts while being inconsistent with their circulation profiles, when directly administered, produce potential interference in virus replication, morphology, and mRNA levels in SARS-CoV-2-treated cells, similar to that observed in in vitro studies on more than 38,597 herbal crude extracts (PubMed, 2020/5/4). However, the use of herbal products such as LH and LS is not Furthermore, their unabsorbed compounds, concentrations of absorbed compounds, excipients, metal ions, and impurities in crude extract may lead to false responses ex vivo after administration. The precise content of the above-mentioned herbal ABCs has remained elusive [4] . Methods such as the bioethnopharmaceutical analytical pharmacology strategy we propose here in which three ABCs almost replicate multi-herbal cardioprotection within 3 months [5] are indeed useful. Nonetheless, generally, the experimental time for in vivo profiling, including that for the above, is longer than that for in vitro profiling, which is unsuitable for rapid screening of antivirals and overcoming the challenge. Herein, we developed a rapid strategy for eliminating false ex vivo responses to LH in H2O2-treated Huh-7 cells by using LH post-dose supernatant of deproteinized serum (LPSDS) as the herbal LH proxy for ex vivo samples. H2O2, a well-known stressor of inflammation and oxidative stress, is an indispensable mediator and inducer of oxidative damage via reactive oxygen species (ROS) generation and inflammatory cytokine-induced damage following coronavirus attack [6, 7] . H2O2-treated endothelium cells induced relevant time-and dose-specific not dependent changes in ROS levels (unpublished data), whereas Huh-7 cells treated for a fixed time with a fixed dose of H2O2 induced a relatively stable increase in ROS levels ( Fig 1C) . After oral administration of LH to rats, the proxy LPSDS, wherein proteins in serum are removed by using a hot water bath, was consistent with the amount circulating in ex vivo systems without any interference. This approach has been successfully applied to increased TNF-α levels by ~4.0- [1] and ~7.0-fold (vs. blank, in Fig 1B) , respectively. We compared crude LH (Lot No. B2001019 [1] ; its nine chromatographic peaks were detected) extracts with LPSDS by using these indices for their consistency. The present LH ex vivo dose (150-600 μg·mL -1 [1] ) was almost identical to ~5%-19% (bioavailability) of conversion in vivo dose following calculation via coefficient 6.7 [5] for a rat (0.1541 g·kg -1 ), which is conversion dose from patient dose (0.0230 g·kg -1 ) [3] . The theoretical bioavailability in rats is 0%-100%, i.e. blank dose to complete absorption, with the latter observed near sites of intravascular injection. Apoptosis as an originally designed cellular survival functional index unexpectedly docked just published pathogenesis [10] and the present pharmacology relevant to coronavirus patients in Fig 1D. Although ex vivo responses to BDS and BS were mild (Fig 1A-D) , it is necessary to eliminate this minor interference because of potential endogenous anti-or pro-inflammation [8] . Here, we hypothesize that LH if applied to COVID-19-treated Huh-7 cells in its proxy form (LPSDS) will exhibit stronger attenuation of virus replication and suppression of inflammation. The precise antiviral compounds of LH elucidated in the above-mentioned CSS research could further support this hypothesis. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway Retrospective clinical analysis on treatment of novel coronavirus-infected pneumonia with traditional Chinese medicine Lianhua Qingwen Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica Cardioprotection by Guanxin II in rats with acute myocardial infarction is related to its three compounds Hydrogen peroxide and viral infections: A literature review with research hypothesis definition in relation to the current COVID-19 pandemic Is low alveolar type II cell SOD3 in the lungs of elderly linked to the observed severity of COVID-19? Symptomatic SARS-CoV-2 infections display specific IgG Fc structures Bioavailability of the polyphenols: status and controversies Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells The authors have no conflict of interest to declare with respect to this manuscript. Xi Huang as the correspondence author designed this work, provided funding, and wrote the letter to the editor; Qiulong Zhao, Liang Xia, and Shaoqi Shi conducted experiments, data analyses, and submitted manuscript. All authors reviewed and approved the final version.